IGF2 signaling and regulation in cancer

Jurriaan Brouwer-Visser, Gloria S. Huang

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Upregulation of IGF2 occurs in both childhood and adult malignancies. Its overexpresssion is associated with resistance to chemotherapy and worse prognosis. IGF2 promoter usage is developmentally regulated; however, malignant tissues are characterized by re-activation of the fetal IGF2 promoters, especially P3. In this review, we describe the mechanisms of IGF2 signaling and regulation in normal and malignant tissues and their clinical implications.

Original languageEnglish (US)
Pages (from-to)371-377
Number of pages7
JournalCytokine and Growth Factor Reviews
Volume26
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Tissue
Chemotherapy
Neoplasms
Up-Regulation
Chemical activation
Drug Therapy

Keywords

  • Cancer
  • Chemoresistance
  • IGF2

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

IGF2 signaling and regulation in cancer. / Brouwer-Visser, Jurriaan; Huang, Gloria S.

In: Cytokine and Growth Factor Reviews, Vol. 26, No. 3, 01.06.2015, p. 371-377.

Research output: Contribution to journalArticle

Brouwer-Visser, Jurriaan ; Huang, Gloria S. / IGF2 signaling and regulation in cancer. In: Cytokine and Growth Factor Reviews. 2015 ; Vol. 26, No. 3. pp. 371-377.
@article{2ea095dcb6054645b33276452b46f78b,
title = "IGF2 signaling and regulation in cancer",
abstract = "Upregulation of IGF2 occurs in both childhood and adult malignancies. Its overexpresssion is associated with resistance to chemotherapy and worse prognosis. IGF2 promoter usage is developmentally regulated; however, malignant tissues are characterized by re-activation of the fetal IGF2 promoters, especially P3. In this review, we describe the mechanisms of IGF2 signaling and regulation in normal and malignant tissues and their clinical implications.",
keywords = "Cancer, Chemoresistance, IGF2",
author = "Jurriaan Brouwer-Visser and Huang, {Gloria S.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.cytogfr.2015.01.002",
language = "English (US)",
volume = "26",
pages = "371--377",
journal = "Cytokine and Growth Factor Reviews",
issn = "1359-6101",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - IGF2 signaling and regulation in cancer

AU - Brouwer-Visser, Jurriaan

AU - Huang, Gloria S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Upregulation of IGF2 occurs in both childhood and adult malignancies. Its overexpresssion is associated with resistance to chemotherapy and worse prognosis. IGF2 promoter usage is developmentally regulated; however, malignant tissues are characterized by re-activation of the fetal IGF2 promoters, especially P3. In this review, we describe the mechanisms of IGF2 signaling and regulation in normal and malignant tissues and their clinical implications.

AB - Upregulation of IGF2 occurs in both childhood and adult malignancies. Its overexpresssion is associated with resistance to chemotherapy and worse prognosis. IGF2 promoter usage is developmentally regulated; however, malignant tissues are characterized by re-activation of the fetal IGF2 promoters, especially P3. In this review, we describe the mechanisms of IGF2 signaling and regulation in normal and malignant tissues and their clinical implications.

KW - Cancer

KW - Chemoresistance

KW - IGF2

UR - http://www.scopus.com/inward/record.url?scp=84929654387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929654387&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2015.01.002

DO - 10.1016/j.cytogfr.2015.01.002

M3 - Article

VL - 26

SP - 371

EP - 377

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

IS - 3

ER -